Eledon Pharmaceuticals, Inc. is a clinical stage biotechnology company using its expertise in targeting the CD40L pathway to develop potential treatments for people undergoing organ or cellular transplantation, and for people with autoimmune and neurodegenerative disease.
Investors 4
| Date | Name | Website |
| - | Apple Tree... | appletreep... |
| - | OrbiMed | orbimed.co... |
| - | Vivo Capit... | vivocapita... |
| - | LifeSci Ve... | lifesciven... |
Mentions in press and media 1
| Date | Title | Description |
| 08.01.2021 | ATP and Biolojic Design Launch Aulos Bioscience to Develop Highly Differentiated IL-2 Antibody Approach to Fighting Cancer | Immuno-oncology spinout from Biolojic Design created with $40M Series A financing from ATP Aulos Bioscience to Present at the 39th Annual J.P. Morgan Healthcare Conference BOSTON and TEL AVIV, January 8, 2021/PR NEWSWIRE/ – ATP, a leading... |